PBH Prestige Consumer Healthcare Inc.

Overview and Growth

In fiscal 2026, Prestige Consumer Healthcare Inc. recorded $1.09B of revenue, net income of $190.30M, and an operating cash inflow of $257.63M. At $1.09B, the top line establishes the operating scale supporting the company’s profit and cash-flow profile. Revenue was 4.3% below fiscal 2025 revenue of $1.14B, marking a top-line contraction. On a per-share basis, diluted EPS was $3.91, which connects the reported earnings outcome with the company’s diluted share count. Against diluted EPS of $4.29 in fiscal 2025, the current result was 8.9% lower. The revenue-to-assets relationship was 0.31x, showing the sales generated relative to the resources carried on the balance sheet.

Profitability

After reported cost of revenue, the company retained $595.58M as gross profit before recognizing operating expenses and other items. The gross-profit relationship equaled 54.7% of revenue, quantifying the portion retained before operating expenses were recognized. The reported operating result was $309.41M, capturing profitability after direct costs and the operating expenses reflected in the statements. Relative to revenue, operating income represented 28.4%, showing how efficiently sales converted into operating profit. Net income came to $190.30M, completing the progression from revenue through gross and operating profitability to the final reported result. Net margin was 17.5%, meaning that this portion of revenue remained as net income after all recognized expenses. Before income taxes, the company reported $257.50M of earnings, providing a bridge between the operating result and final net income. Measured against revenue, pretax income equaled 23.7%, adding a pre-tax profitability layer between revenue and net income. The reported income-tax provision was $67.19M, the amount recognized between pretax income and the final net-income result. The effective relationship between income tax and positive pretax income was 26.1%, without assuming a statutory-rate comparison.

Liquidity and Capital Structure

At period end, the $3.49B asset base was financed through $1.61B of liabilities and $1.89B of equity. The near-term balance sheet paired $431.48M of current assets with $120.92M of current liabilities at the reporting date. Current assets covered current liabilities by 3.57x, leaving a positive buffer for near-term obligations. Cash and equivalents totaled $63.87M, identifying the most liquid reported component available within the broader current-asset balance. Cash and equivalents represented 52.8% of current liabilities, showing the portion of near-term obligations matched by reported cash alone. The company carried $993.95M of total debt at period end, which frames its leverage and debt-service burden. Debt equaled 0.53x of book equity, describing the relative scale of borrowing and shareholder capital. Debt represented 28.4% of total assets, placing borrowing in the context of the company’s full resource base. The liabilities-to-assets relationship was 46.0%, placing reported obligations against the full positive asset balance. The cash-to-assets relationship was 1.8%, comparing reported cash and equivalents with the full positive asset balance.

Cash Flow and Earnings Quality

Operating activities produced a cash inflow of $257.63M, giving the cash-flow counterpart to the accrual-based profit measures reported for the year. Operating cash flow equaled 1.35x of net income, showing how strongly accounting earnings converted into cash from operations. The cash-flow statement records $11.18M of capital expenditures, the investment amount considered after operating cash generation. Capital spending absorbed 4.3% of operating cash flow, quantifying the share of cash from operations directed to investment. After capital spending, free cash flow was $246.45M, leaving cash available for debt reduction, shareholder returns, or further investment. Relative to revenue, free cash flow equaled 22.6%, showing how much sales converted into cash after investment. Free cash flow equaled 7.1% of total assets, relating post-investment cash generation to the company’s resource base.

Based on the annual report for the fiscal year ending Mar 31, 2026. Analysis generated Sep 24, 2026.